OCULAR THERAPEUTIX, INC (OCUL) Insider Trading -- Recent Executive & Director Transactions
17 insiders reported 81 Form 4 transactions for OCULAR THERAPEUTIX, INC (OCUL) over the past 18 months (most recent 2026-10-06). Recent activity: Heier Jeffrey S. (Chief Scientific Officer) Sell 10,869 shares, Kaiser Peter (Chief Development Officer) Sell 9,990 shares, Notman Donald (Chief Operating Officer) Sell 1,099 shares, Heier Jeffrey S. (Chief Scientific Officer) Sell 3,296 shares, Dugel Pravin (Executive Chairman, President and CEO) Sell 21,649 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-06 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 10,869 | $76,626 |
| 2026-10-06 | Kaiser Peter | Chief Development Officer | Sell | 9,990 | $70,430 |
| 2026-09-02 | Notman Donald | Chief Operating Officer | Sell | 1,099 | $11,254 |
| 2026-08-26 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 3,296 | $35,531 |
| 2026-08-26 | Dugel Pravin | Executive Chairman, President and CEO | Sell | 21,649 | $233,160 |
| 2026-08-26 | Kaiser Peter | Chief Development Officer | Sell | 3,035 | $32,687 |
| 2026-08-26 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,897 | $20,450 |
| 2026-08-26 | Dugel Pravin | Executive Chairman, President and CEO | Sell | 50,092 | $0 |
| 2026-08-26 | Dugel Pravin | Executive Chairman, President and CEO | Buy | 50,092 | $0 |
| 2026-06-18 | Dugel Pravin | Executive Chairman, President and CEO | Sell | 50,092 | $0 |
| 2026-06-18 | Dugel Pravin | Executive Chairman, President and CEO | Buy | 50,092 | $0 |
| 2026-06-12 | Warden Charles M | Director | Buy | 14,000 | $0 |
| 2026-06-12 | RAINES MERILEE | Director | Buy | 14,000 | $0 |
| 2026-06-12 | LINDSTROM RICHARD L MD | Director | Buy | 14,000 | $0 |
| 2026-06-12 | Robins Jason Shand | Chief Financial Officer | Buy | 15,441 | $0 |
| 2026-06-12 | Graves Adrienne L | Director | Buy | 14,000 | $0 |
| 2026-06-12 | Williams Leslie J. | Director | Buy | 14,000 | $0 |
| 2026-06-12 | Hong Seung Suh | Director | Buy | 14,000 | $0 |
| 2026-06-05 | Waheed Nadia | Chief Medical Officer | Sell | 14,828 | $122,628 |
| 2026-05-28 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,858 | $15,236 |
| 2026-05-28 | Dugel Pravin | Executive Chairman, President and CEO | Sell | 21,156 | $173,479 |
| 2026-05-28 | Dugel Pravin | Executive Chairman, President and CEO | Sell | 394,696 | $0 |
| 2026-05-28 | Dugel Pravin | Executive Chairman, President and CEO | Buy | 394,696 | $0 |
| 2026-05-28 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 3,018 | $24,748 |
| 2026-05-28 | Kaiser Peter | Chief Development Officer | Sell | 2,967 | $24,329 |
Source: SEC Form 4 filings · as of 2026-10-06